2053-4221

EMJ Hepatology

European Medical Group

Health Score

0 Poor

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add license metadata to 144 records

License metadata tells indexers and readers how each article may be reused.

High impact144 DOIs
2

Attach ORCID iDs across 140 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact140 DOIs
3

Add abstracts to 50 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact50 DOIs

DOIs for this ISSN

Showing the top 5 of 143 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Overlapping Clinical Features Between NAFLD and Metabolic Sy… (10.33590/emjhepatol/10312322)
References ORCID License
63.38 6
2 Acute Liver Failure: Pathophysiologic Basis, and The Current… (10.33590/emjhepatol/10313515)
References ORCID License
52.42 4
3 Liver Fibrosis: A Clinical Update (10.33590/emjhepatol/10313576)
ORCID License
52.07 10
4 Overlap Syndrome with Autoimmune Hepatitis and Primary Scler… (10.33590/emjhepatol/10313935)
ORCID License
52.07 10
5 Adipose Tissue, Metabolic Syndrome, and Non-Alcoholic Fatty… (10.33590/emjhepatol/10311666)
References ORCID License
45.15 3
6 Hepatic Encephalopathy: A Review (10.33590/emjhepatol/21-00030)
ORCID License
42.25 6
7 Difficult Biliary Cannulation in Endoscopic Retrograde Chola… (10.33590/emjhepatol/21-00005)
ORCID License
38.91 5
8 Cholangioscopy and its Primary Sclerosing Cholangitis (10.33590/emjhepatol/20-00020)
References ORCID License
35.78 2
9 Barriers and Motivators for Implementation of Lifestyle Chan… (10.33590/emjhepatol/dfof9828)
Abstract ORCID License
35.78 2
10 Hepatocellular Carcinoma. Part 2: Clinical Presentation and… (10.33590/emjhepatol/10311703)
ORCID License
34.95 4
11 Primary Hepatic Angiosarcoma: A Brief Review of the Literatu… (10.33590/emjhepatol/10314175)
ORCID License
34.95 4
12 Thermal Ablation of Liver Tumours: How the Scenario Has Chan… (10.33590/emjhepatol/10314486)
ORCID License
34.95 4
13 Difficult Biliary Cannulation in Endoscopic Retrograde Chola… (10.33590/emjhepatol/20-00283)
ORCID License
34.95 4
14 Definitions of Acute-On-Chronic Liver Failure: The Past, the… (10.33590/emjhepatol/10310827)
ORCID License
30.10 3
15 Macrophages in Nonalcoholic Steatohepatitis: Friend or Foe? (10.33590/emjhepatol/10312252)
ORCID License
30.10 3
16 Acute Fatty Liver of Pregnancy: Better Understanding of Path… (10.33590/emjhepatol/10314416)
ORCID License
30.10 3
17 Overview of Alpha-1 Antitrypsin Deficiency-Mediated Liver Di… (10.33590/emjhepatol/10314658)
ORCID License
30.10 3
18 Hepatitis B Care Pathway in the United Arab Emirates: Curren… (10.33590/emjhepatol/19-00061)
ORCID License
30.10 3
19 The Challenging Ethical Landscape of Non-alcoholic Fatty Liv… (10.33590/emjhepatol/21-00217)
ORCID License
30.10 3
20 Progressive Familial Intrahepatic Cholestasis in Adulthood:… (10.33590/emjhepatol/hfcn9816)
Abstract References ORCID License
30.10 1
21 How to Identify MASLD Forms Secondary to Endocrine Derangeme… (10.33590/emjhepatol/qvcy8477)
ORCID License
30.10 3
22 Cirrhosis: Reviewing the Literature and Future Perspectives (10.33590/emj/10310535)
ORCID License
23.86 2
23 A Look at Platelet Count in Chronic Hepatitis C Infection (10.33590/emjhepatol/10310346)
ORCID License
23.86 2
24 Percutaneous Laser Thermal Ablation in a Patient with 22 Liv… (10.33590/emjhepatol/10310574)
ORCID License
23.86 2
25 Targeting the Relaxin Pathway for Liver Disease Treatment (10.33590/emjhepatol/10311638)
ORCID License
23.86 2
26 Hepatitis B Care Pathway in the United Arab Emirates: Curren… (10.33590/emjhepatol/10313909)
ORCID License
23.86 2
27 Metabolic Syndrome in Paediatric Population: Is it Time to T… (10.33590/emjhepatol/10314218)
ORCID License
23.86 2
28 Rethink Your Transjugular Intrahepatic Portosystemic Shunt (… (10.33590/emjhepatol/19-00204)
ORCID License
23.86 2
29 Liver Disorders in Inflammatory Bowel Disease (10.33590/emjhepatol/20-00040)
ORCID License
23.86 2
30 Towards a Standardised Method to Acquire and Store Liver Sam… (10.33590/emjhepatol/10310760)
References ORCID License
22.58 1
31 Cost-Effective Interventions in The Control of Chronic Hepat… (10.33590/emjhepatol/10313405)
References ORCID License
22.58 1
32 Cellular Consequences of Z Alpha-1 Antitrypsin Accumulation… (10.33590/emjhepatol/10314058)
References ORCID License
22.58 1
33 Gut Dysbiosis is Associated With the Severity of Liver Fibro… (10.33590/emjhepatol/hwda3400)
Abstract ORCID License
22.58 1
34 Mitigation of Immune Dysfunction in Patients with Sustained… (10.33590/emjhepatol/oivh1936)
Abstract ORCID License
22.58 1
35 Review of the European Association for the Study of the Live… (10.33590/emjhepatol/sdvc9205)
Abstract ORCID License
22.58 1
36 MASH Redefined: Insights from the EASL Congress 2025 (10.33590/emjhepatol/suix7527)
Abstract ORCID License
22.58 1
37 Nothing About Me Without Me: Shared Decision-Making in Chron… (10.33590/emjhepatol/10064379)
ORCID License
15.05 1
38 Primary Biliary Cholangitis in Motion Meeting (10.33590/emjhepatol/10310613)
ORCID License
15.05 1
39 Immunopathogenesis of Hepatitis B Virus Infection and Relate… (10.33590/emjhepatol/10311006)
ORCID License
15.05 1
40 Non-Malignant Portal Vein Thrombosis in Liver Cirrhosis: Dia… (10.33590/emjhepatol/10311905)
ORCID License
15.05 1
41 Homozygosity For The C282Y Substitution In The HFE Gene: The… (10.33590/emjhepatol/10312409)
ORCID License
15.05 1
42 Hepatic-Based Inborn Errors of Metabolism (10.33590/emjhepatol/10313902)
ORCID License
15.05 1
43 Paediatric Metabolic Conditions of the Liver (10.33590/emjhepatol/10314668)
ORCID License
15.05 1
44 Non-Alcoholic Fatty Liver Disease – Changing the Prevalence… (10.33590/emjhepatol/10314903)
ORCID License
15.05 1
45 Gastrointestinal Manifestations and Liver Injury: Correlatio… (10.33590/emjhepatol/20-00233)
ORCID License
15.05 1
46 Frequency Distribution of Hepatitis C Virus Genotypes with R… (10.33590/emjhepatol/20-00268)
ORCID License
15.05 1
47 Secondary Bacterial Peritonitis Due to an Inadequately Treat… (10.33590/emjhepatol/bwfu9578)
ORCID License
15.05 1
48 Improving Assessment of Steatotic Liver Disease with Non-inv… (10.33590/emj/gjun4017)
Abstract ORCID License
0.00 0
49 Interview with Frank Tacke: Rethinking Hepatic Inflammation (10.33590/emjhepatol/09mqe52p)
Abstract References ORCID License
0.00 0
50 Pre-transplant Changes in Serum Protein Glycosylation Relate… (10.33590/emjhepatol/10020546)
Abstract References ORCID License
0.00 0